Consensus-Based Guidelines for the Treatment of Atopic Dermatitis in Korea (Part II): Biologics and JAK inhibitors.

ABSTRACT:

Background

Atopic dermatitis (AD) is a common skin disease with a wide range of symptoms. Due to the rapidly changing treatment landscape, regular updates to clinical guidelines are needed.

Objective

This study aimed to update the guidelines for the treatment of AD to reflect recent therapeutic advances and evidence-based recommendations.

Methods

The Patient characteristics, type of Intervention, Control, and Outcome framework was used to determine 48 questions related to AD management. Evidence was graded, recommendations were determined, and, after 2 voting rounds among the Korean Atopic Dermatitis Association (KADA) council members, consensus was achieved.

Results

This guideline provides treatment guidance on advanced systemic treatment modalities for AD. In

SUBMITTER: Ko HC 

PROVIDER: S-EPMC12318779 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature